Stina Salomonsson

About me
Publications
CV
Public outreach and news

About me

Current roles
−
Affiliated to the Experimental Rheumatology group, led by professor Marie Wahren-Herlenius, Karolinska Institutet
−
Executive Director, Value &
Implementation Outcomes Research, MSD
−
Alliance Manager for strategic partnership between Karolinska Institutet and MSD

Research

Former research experiences
-
Post doc at Department of Physiology and Department of Rheumatology, Karolinska Institutet
−
International experience from PhD and postdoc from University of Bergen, Norway, Radboud University in Nijmegen, the Netherlands
−
Recieved the Göran Gustafssons prize in Medicine, the Nanna Svartz prize for Rheumatologic research, Scandinavian Journal of Rheumatology's prize for rheumatologic research, the IMID-prise for research on immune-mediated inflammatory disease from the Swedish societies of dermatology, rheumatology and gastroenterology
−
Appointed as the Swedish Pharmaceutical profile of the Year, 2021
−
Price for best thesis at Karolinska Institutet year 2004, 2005
−
Personal scholarship from Queen Silvia’s Jubileumsfond, 2002
−
Marie Curie fellowship scholarship funded by the European Union, for exchange at Broegelmann Research Laboratory in Bergen, Norway, 2002

Education
−
PhD thesis in Experimental Medicine 2004, Department of Medicine Solna, Karolinska Institutet

Articles

Journal article: JOURNAL OF MEDICAL ECONOMICS. 2024;27(1):858-865
Assessing the fiscal consequences of novel and existing treatments for triple negative breast cancer in Switzerland by applying a government perspective framework.
Copeland C; Kotsopoulos N; Favre-Bulle A; Bencina G; Sönmez D; Salomonsson S
Journal article: AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2024;36(1):146
Impact of lower-respiratory tract infections on healthcare utilization and mortality in older adults: a Swedish population-based cohort study
Abbadi A; Gentili S; Tsoumani E; Brandtmueller A; Hendel MK; Salomonsson S; Calderon-Larranaga A; Vetrano DL
Journal article: ACTA ONCOLOGICA. 2024;63:198-205
First-line treatment patterns and outcomes in advanced non-small cell lung cancer in Sweden: a population-based real-world study with focus on immunotherapy
Wagenius G; Vikstrom A; Berglund A; Salomonsson S; Bencina G; Hu X; Chirovsky D; Brunnstrom H
Article: JAMA NETWORK OPEN. 2024;7(1):e2352402
Increased Risk of Long-Term Disabilities Following Childhood Bacterial Meningitis in Sweden.
Mohanty S; Johansson Kostenniemi U; Silfverdal SA; Salomonsson S; Iovino F; Sarpong EM; Bencina G; Bruze G
Journal article: JOURNAL OF MEDICAL ECONOMICS. 2023;26(1):254-261
Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs.
Bencina G; Chami N; Hughes R; Weston G; Baxter C; Maciejczyk A; Popovic L; Karamousouli E; Salomonsson S
Journal article: EXPERT REVIEW OF VACCINES. 2023;22(1):148-160
Estimating the lifetime cost of vaccination in 23 European Countries: a modeling study.
Bencina G; Bento-Abreu A; Sabale U; Tsoumani E; Laigle V; Dauby N; Ethgen O; Salomonsson S
Journal article: EXPERT REVIEW OF VACCINES. 2023;22(1):876-884
Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review.
Tsoumani E; Carter JA; Salomonsson S; Stephens JM; Bencina G
Journal article: VALUE IN HEALTH. 2023;26(12):s251-s252
EPH265 Updated Estimations of the HPV Vaccination Deficit Among Girls in Greece: Early Signs of Recovery?
Gountas I; Skroumpelos A; Trimis G; Markoulatos N; Sabale U; Salomonsson S; Saxena K; Poughias L; Karokis A
Journal article: ANNALS OF ONCOLOGY. 2023;34:s539
Mental and socioeconomic burden in co-parents and children of patients with endometrial and cervical cancer: A Swedish population-based study
Sundstrom K; Bencina G; Andersson M; Salomonsson S; Fang F; Wang J
Journal article: ADVANCES IN THERAPY. 2023;40(7):3056-3069
Indirect Costs Due to Lung Cancer-Related Premature Mortality in Four European Countries.
Bencina G; Chami N; Hughes R; Weston G; Baxter C; Salomonsson S; Demedts I
Journal article: JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH. 2023;:102-110
HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review
Bencina G; Petrova E; Sönmez D; Matos Pereira S; Dimitriadis I; Salomonsson S
Journal article: EXPERT REVIEW OF PHARMACOECONOMICS AND OUTCOMES RESEARCH. 2023;23(4):391-398
Assessing the impact of kidney cancer-related premature mortality and productivity loss in Greece and Portugal.
Bencina G; Chami N; Hughes R; Weston G; Baxter C; Salomonsson S
Journal article: JOURNAL OF THORACIC ONCOLOGY. 2023;18(4):s71-s72
51P Real-word outcomes of immunotherapy in non-small cell lung cancer: A population-based cohort study in Sweden
Wagenius G; Vikström A; Berglund A; Salomonsson S; Bencina G; Hu X; Chirovsky DR; Brunnström H
Journal article: VACCINES. 2023;11(2):258
Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery.
Gountas I; Favre-Bulle A; Saxena K; Wilcock J; Collings H; Salomonsson S; Skroumpelos A; Sabale U
Journal article: JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH. 2023;10(1):102-110
HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review.
Bencina G; Petrova E; Sönmez D; Matos Pereira S; Dimitriadis I; Salomonsson S
Journal article: VALUE IN HEALTH. 2022;25(12):s153
EE496 Triple Negative Breast Cancer-Related Mortality in Central and Eastern Europe: Years of Life Lost and Productivity Costs
Bencina G; Chami N; Hughes R; Weston G; Baxter C; Karamousouli E; Salomonsson S
Journal article: VALUE IN HEALTH. 2022;25(12):s122
EE343 Assessing Impact of Kidney Cancer-Related Premature Mortality and Productivity Loss in Greece and Portugal
Bencina G; Chami N; Hughes R; Weston G; Baxter C; Salomonsson S
Journal article: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2022;18(5):2060017
Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: A systematic literature review.
Bencina G; Fues Wahl H; Tsoumani E; Salomonsson S
Journal article: ERJ OPEN RESEARCH. 2022;8(4):00232-02022
The demographics, clinical characteristics and quality of life of patients with chronic cough from the Isala Cough Clinic in the Netherlands.
van den Berg JWK; Baxter CA; Edens MA; Patberg KW; van der Velden H; Weijerse A; Salomonsson S
Journal article: JOURNAL OF THORACIC ONCOLOGY. 2022;17(9):s380-s381
EP08.01-083 Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden
Wagenius G; Vikström A; Berglund A; Salomonsson S; Bencina G; Hu X; Chirovsky D; Brunnström H; Ekman S
Journal article: ANNALS OF ONCOLOGY. 2022;33:s1157
1351P Indirect costs due to lung cancer-related premature mortality in four European countries
Bencina G; Chami N; Hughes R; Weston G; Baxter C; Salomonsson S; Demedts I
Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(8):1151-1161
Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function
Meisgen S; Hedlund M; Ambrosi A; Folkersen L; Ottosson V; Forsberg D; Thorlacius GE; Biavati L; Strandberg L; Mofors J; Ramskold D; Ruhrmann S; Meneghel L; Nyberg W; Espinosa A; Hamilton RM; Franco-Cereceda A; Hamsten A; Olsson T; Greene L; Eriksson P; Gemzell-Danielsson K; Salomonsson S; Kuchroo VK; Herlenius E; Kockum I; Sonesson S-E; Wahren-Herlenius M
Journal article: RESPIRATORY MEDICINE. 2022;192:106726
Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in Austria.
Abozid H; Baxter CA; Hartl S; Braun E; Salomonsson S; Breyer-Kohansal R; Breyer MK; Wouters EFM; Agusti A; Burghuber OC
Journal article: JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH. 2022;9(1):20-30
Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products.
Toghanian S; Moshtaghi-Svensson J; Papageorgiou M; Kittelsen K; Dolk C; Hultstrand M; Salomonsson S
Journal article: VALUE IN HEALTH. 2022;25(1):s97
POSC57 The Costs and Time Associated with the Infusions of PD-1 Inhibitors in Melanoma Patients in Sweden
Bencina G; Glader E; Ljungcrantz C; Salomonsson S
Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2021;110(6):1613-1621
Replication of Oncology Randomized Trial Results using Swedish Registry Real World-Data: A Feasibility Study
Jemielita T; Widman L; Fox C; Salomonsson S; Liaw K-L; Pettersson A
Article: EUROPEAN HEART JOURNAL - QUALITY OF CARE AND CLINICAL OUTCOMES. 2021;7(1):59-67
Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17
Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagstrom E; Schubert J; Boggs R; Salomonsson S; Ueda P
Article: JOURNAL OF MEDICAL INTERNET RESEARCH. 2021;23(1):e16842
Sharing Patient-Controlled Real-World Data Through the Application of the Theory of Commons: Action Research Case Study
Hager A; Lindblad S; Brommels M; Salomonsson S; Wannheden C
Journal article: VALUE IN HEALTH. 2020;23:s660
PNS110 Estimating Future Budget Headroom As a Result of Expiration of Exclusivity for Pharmaceuticals Using the Affordability By Reallocating Funds (ART) MODEL
Toghanian S; Papageorgiou M; Kittelsen K; Dolk C; Hultstrand M; Salomonsson S
Journal article: VALUE IN HEALTH REGIONAL ISSUES. 2020;22:s74
PMU29 Real World DATA Availability and Quality in ASIA Pacific. Assessment and Implications for Research and Healthcare Decision-Making
Monsanto H; Salomonsson S; Spiteri C; van Bavel J
Article: JOURNAL OF ALZHEIMER'S DISEASE. 2020;75(3):891-902
Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions
Wimo A; Handels R; Winblad B; Black CM; Johansson G; Salomonsson S; Eriksdotter M; Khandker RK
Journal article: BMC INFECTIOUS DISEASES. 2020;20(1):181
Eliminating viral hepatitis C in Belgium: the micro-elimination approach.
Busschots D; Toghanian S; Bielen R; Salomonsson S; Koc ÖM; Hendrickx G; Jadoul M; Nevens F; Sokal E; Brixko C; Peerlinck K; Apers L; Robaeys G; Lazarus JV
Article: EUROPACE. 2019;21(11):1717-1724
Pacing therapy in children with isolated complete atrioventricular block: a retrospective study of pacing system survival and pacing-related complications in a national cohort
Eliasson H; Sonesson S-E; Salomonsson S; Andreasson AS; Wahren-Herlenius M; Gadler F
Journal article: EUROPEAN HEART JOURNAL. 2019;40(Supplement_1):ehz747.0427
P828Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study
Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagstrom E; Schubert J; Boggs R; Salomonsson S; Ueda P
Journal article: ALZHEIMER'S AND DEMENTIA. 2019;15(7S_Part_9):p501
P1‐588: QUANTIFYING AND DESCRIBING THE NATURAL HISTORY OF AD AND ECONOMIC EFFECTS OF HYPOTHETICAL INTERVENTIONS
Wimo A; Black CM; Chekani F; Eriksdotter M; Johansson G; Handels R; Salomonsson S; Winblad B; Khandker RK
Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(5):696-703
Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero
Mofors J; Eliasson H; Ambrosi A; Salomonsson S; Skog A; Fored M; Ekbom A; Bergman G; Sonesson S-E; Wahren-Herlenius M
Journal article: JOURNAL OF HEPATOLOGY. 2019;70(1):e325
THU-387-Eliminating viral hepatitis C in Belgium: A mathematical model of the micro-elimination approach
Busschots D; Toghanian S; Bielen R; Salomonsson S; Koc O; Hendrickx G; Jadoul M; Nevens F; Sokal E; Brixko C; Peerlinck K; Apers L; Robaeys G; Lazarus J
Journal article: CLINICAL THERAPEUTICS. 2016;38(7):1686-1695.e3
Proportion and Characteristics of Patients in Sweden Remaining at High Risk of Fracture Despite Prior Treatment.
Mellström D; Yang X; Li Z; Fan C-PS; Waern E; Modi A; Sajjan S; Salomonsson S
Article: HEART RHYTHM. 2015;12(11):2278-2284
Outcome in young patients with isolated complete atrioventricular block and permanent pacemaker treatment: A nationwide study of 127 patients
Eliasson H; Sonesson S-E; Salomonsson S; Skog A; Wahren-Herlenius M; Gadler F
Journal article: VALUE IN HEALTH. 2015;18(7):a633
PGI62 Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab In Sweden
Salomonsson S; Söderberg J; Alenadaf K; Ljung T
Article: ARCHIVES OF OSTEOPOROSIS. 2015;10(1):24
Swedish osteoporosis care
Jonsson E; Eriksson D; Akesson K; Ljunggren O; Salomonsson S; Borgstrom F; Strom O
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(Suppl 2):760
SAT0459 Characteristics, Treatments, and Quality of Life of Patients in A Swedish Osteoporosis Patient Registry
Krishna A; Mellström D; Li Z; Fan C-PS; Salomonsson S; Waern E
Article: JOURNAL OF INTERNAL MEDICINE. 2014;275(6):640-651
The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence
Meisgen S; Ostberg T; Salomonsson S; Ding B; Eliasson H; Malarstig A; Alfredsson L; Klareskog L; Hamsten A; Olsson T; Axelsson T; Gadler F; Jonzon A; Sonesson S-E; Kockum I; Wahren-Herlenius M
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2014;103(3):275-281
Late development of complete atrioventricular block may be immune mediated and congenital in origin
Bergman G; Skog A; Tingstrom J; Ottosson V; Hoxha A; Ambrosi A; Salomonsson S; Wahren-Herlenius M
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2013;102(7):718-726
Long-term growth of children with autoantibody-mediated congenital heart block
Skog A; Eliasson H; Tingstrom J; Kallberg H; Salomonsson S; Sonesson S-E; Wahren-Herlenius M
Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2013;102(1):40-46
Neurodevelopment in children with and without congenital heart block born to anti-Ro/SSA-positive mothers
Skog A; Tingstrom J; Salomonsson S; Sonesson S-E; Wahren-Herlenius M
Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(3):334-340
Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern
Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Skog A; Dzikaite V; Bergman G; Fernlund E; Tingstrom J; Theander E; Rydberg A; Skogh T; Ohman A; Lundstrom U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Kallberg H; Olsson T; Gadler F; Jonzon A; Kockum I; Sonesson S-E; Wahren-Herlenius M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2011;74(5):511-517
A Population-based Investigation of the Autoantibody Profile in Mothers of Children with Atrioventricular Block
Salomonsson S; Dzikaite V; Zeffer E; Eliasson H; Ambrosi A; Bergman G; Fernlund E; Theander E; Ohman A; Rydberg A; Skogh T; Wallberg-Jonsson S; Elfving A; Fored M; Ekbom A; Lundstrom U; Mellander M; Winqvist O; Sonesson S-E; Gadler F; Jonzon A; Wahren-Herlenius M
Article: JOURNAL OF IMMUNOLOGY. 2010;185(6):3574-3582
Maternal MHC Regulates Generation of Pathogenic Antibodies and Fetal MHC-Encoded Genes Determine Susceptibility in Congenital Heart Block
Strandberg LS; Ambrosi A; Jagodic M; Dzikaite V; Janson P; Khademi M; Salomonsson S; Ottosson L; Klauninger R; Aden U; Sonesson S-E; Sunnerhagen M; de Graaf KL; Kuchroo VK; Achour A; Winqvist O; Olsson T; Wahren-Herlenius M
Article: JOURNAL OF IMMUNOLOGY. 2009;183(7):4792-4799
T Cell Infiltrates in the Muscles of Patients with Dermatomyositis and Polymyositis Are Dominated by CD28^null T Cells
Fasth AER; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg K-J; Soderberg-Naucler C; Trollmo C; Lundberg IE; Malmstrom V
Article: MUSCLE AND NERVE. 2009;39(5):674-682
UPREGULATION OF MHC CLASS I IN TRANSGENIC MICE RESULTS IN REDUCED FORCE-GENERATING CAPACITY IN SLOW-TWITCH MUSCLE
Salomonsson S; Grundtman C; Zhang S-J; Lanner JT; Li C; Katz A; Wedderburn LR; Nagaraju K; Lundberg IE; Westerblad H
Article: JOURNAL OF ORAL PATHOLOGY & MEDICINE. 2009;38(3):282-288
Minor salivary gland immunohistology in the diagnosis of primary Sjogren's syndrome
Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2008;154(1):30-37
Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block
Strandberg L; Winqvist O; Sonesson S-E; Mohseni S; Salomonsson S; Bremme K; Buyon JP; Julkunen H; Wahren-Herlenius M
Article: ARTHRITIS & RHEUMATOLOGY. 2007;56(2):674-687
Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Article: METHODS IN MOLECULAR MEDICINE. 2007;136:19-24
Detection of antigen specific B-cells in tissues.
Wahren-Herlenius M; Salomonsson S
Article: LUPUS. 2006;15(6):346-353
Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies
Strandberg L; Salomonsson S; Bremme K; Sonesson S-E; Wahren-Herlenius M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2005;62(6):552-559
Elevated serum levels of soluble E-cadherin in patients with primary Sjogren's syndrome
Jonsson MV; Salomonsson S; Oijordsbakken G; Skarstein K
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2005;61(2):109-118
Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein
Ottosson L; Salomonsson S; Hennig J; Sonesson SE; Dörner T; Raats J; Kuchroo VK; Sunnerhagen M; Wahren-Herlenius M
Article: JOURNAL OF EXPERIMENTAL MEDICINE (JEM). 2005;201(1):11-17
Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block
Salomonsson S; Sonesson SE; Ottosson L; Muhallab S; Olsson T; Sunnerhagen M; Kuchroo VK; Thorén P; Herlenius E; Wahren-Herlenius M
Article: ARTHRITIS & RHEUMATOLOGY. 2004;50(4):1253-1261
Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies
Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
Article: JOURNAL OF AUTOIMMUNITY. 2004;22(2):167-177
Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block
Salomonsson S; Ottosson L; Säfsten P; Hof D; Brauner H; Sunnerhagen M; Raats J; Wahren-Herlenius M
Article: ARTHRITIS & RHEUMATOLOGY. 2003;48(11):3187-3201
Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome
Salomonsson S; Jonsson MV; Skarstein K; Brokstad KA; Hjelmström P; Wahren-Herlenius M; Jonsson R
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2003;32(2):79-82
Local production of Ro/SSA and La/SSB autoantibodies in the target organ coincides with high levels of circulating antibodies in sera of patients with Sjogren's syndrome
Salomonsson S; Wahren-Herlenius M
Article: ARTHRITIS & RHEUMATOLOGY. 2002;46(5):1233-1241
A serologic marker for fetal risk of congenital heart block
Salomonsson S; Dörner T; Theander E; Bremme K; Larsson P; Wahren-Herlenius M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2002;55(4):336-342
Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren's syndrome
Salomonsson S; Larsson P; Tengnér P; Mellquist E; Hjelmström P; Wahren-Herlenius M
Article: JOURNAL OF RHEUMATOLOGY. 2001;28(2):373-376
Primary Sjogren's syndrome - Treatment of fetal incomplete atrioventricular block with dexamethasone
Theander E; Brucato A; Gudmundsson S; Salomonsson S; Wahren-Herlenius M; Manthorpe R
Show more

All other publications

Conference publication: ANNALS OF ONCOLOGY. 2023;34:s538
Mental and socioeconomic burden in endometrial and cervical cancer patients: A Swedish population-based study of survivorship
Wang J; Feldman AL; Bencina G; Andersson M; Salomonsson S; Fang F; Sundstrom K
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(4):S71-S72
Real-word outcomes of immunotherapy in non-small cell lung cancer: A population-based cohort study in Sweden
Wagenius G; Vikstrom A; Berglund A; Salomonsson S; Bencina G; Hu X; Chirovsky DR; Brunnstrom H
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2022;17(9):S380-S381
Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden
Wagenius G; Vikstrom A; Berglund A; Salomonsson S; Bencina G; Hu X; Chirovsky D; Brunnstrom H; Ekman S
Conference publication: 2021;:pa1953
Definition, characteristics and quality of life of patients with chronic cough from the Isala chronic cough clinic in the Netherlands
Van Den Berg JWK; Baxter CA; Edens M; Patberg KW; van der Velden H; Weijerse A; Salomonsson S
Conference publication: 2020;:a7645
Phenotypes and Characteristics of Chronic Cough in a General Population- The Austrian Lead Study
Abozid H; Baxter C; Hartl S; Salomonsson S; Breyer- Kohansal R; Breyer M-KK; Ofenheimer A; Braun E; Schrott A; Burghuber OCC
Letter: EUROPACE. 2020;22(2):330-331
Pacing therapy in children with isolated complete atrioventricular block: a retrospective study of pacing system survival and pacing-related complications in a national cohort-Authors' reply
Eliasson H; Sonesson S-E; Salomonsson S; Andreasson AS; Wahren-Herlenius M; Gadler F
Preprint: JMIR PREPRINTS. 2019
Sharing Patient-Controlled Real-World Data Through the Application of the Theory of Commons: Action Research Case Study (Preprint)
Hager A; Lindblad S; Brommels M; Salomonsson S; Wannheden C
Review: BMJ OPEN. 2019;9(5):e027456
Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review
Luttropp K; Dozier M; Justo N; Cornillie F; Kachroo S; Govoni M; Salomonsson S; Black CM; Khalifa A
Conference publication: EUROPEAN HEART JOURNAL. 2019;40:429
Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study
Allahyari A; Jernberg T; Lautsch D; Lundman P; Hagstrom E; Schubert J; Boggs R; Salomonsson S; Ueda P
Meeting abstract: VALUE IN HEALTH. 2018;21:S439
REAL WORLD TREATMENT PERSISTANCE OF GOLIMUMAB IN THE MANAGEMENT OF IMMUNE-MEDIATED RHEUMATIC DISEASES (IMRDS) IN EUROPE: A SYSTEMATIC LITERATURE REVIEW (SLR)
Justo N; Black C; Dozier M; Lutropp K; Kachroo S; Govoni M; Salomonsson S; Khalifa A
Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(9):1381-1382
European families reveal MHC class I and II associations with autoimmune-mediated congenital heart block
Kyriakidis NC; Kockum I; Julkunen H; Hoxha A; Salomonsson S; Meneghel L; Ebbing C; Dilthey A; Eronen M; De Carolis S; Kiserud T; Ruffatti A; Kere J; Meisgen S; Wahren-Herlenius M
Conference publication: HEPATOLOGY. 2018;68:891A
Daa Treatment Associated with Longer Survival in Swedish Patients with Chronic Hepatitis c (CHC) and Chronic Kidney Disease (CKD)
Bruchfeld A; Carrero JJ; Salomonsson S; Lagerbaeck G; Puenpatom A; Levin A; Lindahl K
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67
Auxilin Is a Novel Susceptibility Gene for Congenital Heart Block Modulating Cardiac Function
Meisgen S; Hedlund M; Ambrosi A; Folkersen L; Dzikaite-Ottosson V; Ding B; Strandberg L; Biavati L; Ramskold D; Forsberg D; Bergin L; Ruhrmann S; Hamilton RM; Franco-Cereceda A; Hamsten A; Olsson T; Greene L; Eriksson P; Gemzell-Danielsson K; Salomonsson S; Kuchroo VK; Herlenius E; Kockum I; Sonesson S-E; Wahren-Herlenius M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:A56
The HLA Locus Contains Novel Foetal Susceptibility Alleles For Congenital Heart Block with Significant Paternal Influence
Gorgen S; Ostberg T; Salomonsson S; Ding B; Eliasson H; Malarstig A; Alfredsson L; Klareskog L; Hamsten A; Olsson T; Axelsson T; Gadler F; Jonzon A; Sonesson S-E; Kockum I; Wahren-Herlenius M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2012;71:a60
IDENTIFICATION OF NOVEL GENETIC RISK LOCI DETERMINE FETAL OUTCOME IN CONGENITAL HEART BLOCK
Gorgen S; Ding B; Salomonsson S; Klareskog L; Hamsten A; Hillert J; Alfredsson L; Olsson T; Kockum I; Wahren-Herlenius M
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2012;71:a86
NEUROPSYCHIATRIC DEVELOPMENT AND HEALTH IN CHILDREN WITH AND WITHOUT CONGENITAL HEART BLOCK BORN TO MOTHERS WITH RO/SSA AUTOANTIBODIES - A RETROSPECTIVE FOLLOW-UP
Skog A; Tingstrom J; Salomonsson S; Sonesson S-E; Wahren-Herlenius M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2012;76(2):196
Neuropsychiatric Development in Children with and without CHB Born to Mothers with Anti-Ro52/SSA Autoantibodies
Skog A; Tingstrom J; Salomonsson S; Sonesson S-E; Wahren-Herlenius M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2012;76(2):208
Identification of Novel Genetic Risk Loci Associated with Fetal Outcome in Congenital Heart Block
Gorgen S; Ding B; Salomonsson S; Klareskog L; Hamsten A; Hillert J; Alfredsson L; Olsson T; Kockum I; Wahren-Herlenius M
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2011;70:a87-A88
DEVELOPMENT OF HEART BLOCK IN SSA/SSB AUTOANTIBODY-POSITIVE PREGNANCIES IS ASSOCIATED WITH MATERNAL AGE AND DISPLAY A SEASON-OF-BIRTH PATTERN
Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Dzikaite V; Bergman G; Fernlund E; Theander E; Rydberg A; Skogh T; Wallberg-Jonsson S; Ohman A; Lundstrom U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Kallberg H; Gadler F; Jonzon A; Sonesson S-E; Wahren-Herlenius M
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2011;70:A16
HLA-DRB1*04 IS A NOVEL FETAL SUSCEPTIBILITY ALLELE IN CONGENITAL HEART BLOCK
Ostberg T; Gorgen S; Salomonsson S; Ding B; Eliasson H; Elfving A; Malarstig A; Alfredsson L; Klareskog L; Hamsten A; Olsson T; Padukov L; Axelsson T; Gadler F; Jonzon A; Sonesson SE; Kockum I; Wahren-Herlenius M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2011;73(4):370
HLA-DRB1*04 is a Novel Fetal Susceptibility Allele in Congenital Heart Block
Ostberg T; Gorgen S; Salomonsson S; Ding B; Eliasson H; Elfving A; Malarstig A; Alfredsson L; Klareskog L; Hamsten A; Olsson T; Padukov L; Axelsson T; Gadler F; Jonzon A; Sonesson S-E; Kockum I; Wahren-Herlenius M
Review: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2010;72(3):185-188
Autoantibodies Associated with Congenital Heart Block
Salomonsson S; Strandberg L
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2010;72(3):274-275
A Population-Based Investigation of the Autoantibody Profile in Mothers of Children with Atrioventricular Block
Zeffer E; Salomonsson S; Dzikaite V; Eliasson H; Ambrosi A; Bergman G; Fernlund E; Theander E; Ohman A; Rydberg A; Skogh T; Rantapaa-Dahlqvist S; Elfving A; Fored M; Blomqvist P; Ekbom A; Lindstrom U; Melander M; Winqvist O; Sonesson S-E; Gadler F; Jonzon A; Wahren-Herlenius M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2010;72(3):265
Influence of Season of Birth and Maternal Age in the Development of Congenital Heart Block in Anti-Ro-SSA/La-SSB Positive Pregnancies
Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Dzikaite V; Bergman G; Fernlund E; Theander E; Ryberg A; Ohman A; Skogh T; Rantapaa S; Fored M; Blomqvist P; Ekbom A; Lindsrtom U; Melander M; Winqvist O; Gadler F; Jonzon A; Sonesson S-E; Wahren-Herlenius M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2010;72(3):269-270
HLA-DRB1*04 is a Novel Fetal Susceptibility Gene Variant in Congenital Heart Block
Ostberg T; Salomonsson S; Ding B; Eliasson H; Elfving A; Malarstig A; Alfredsson L; Klareskog L; Hamsten A; Olsson T; Padukov L; Axelsson T; Gadler F; Jonzon A; Sonesson S-E; Kockum I; Wahren-Herlenius M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2010;72(3):269
MHC Genes Determine Fetal Susceptibility in a Rat Model of Congenital Heart Block
Dzikaite V; Strandberg LS; Ambrosi A; Jagodic M; Janson P; Khademi M; Salomonsson S; Ottosson L; Klauninger R; Aden U; Sonesson S-E; Sunnerhagen M; de Graaf KL; Kuchroo VK; Achour A; Winqvist O; Olsson T; Wahren-Herlenius M
Meeting abstract: CLINICAL IMMUNOLOGY. 2008;127:s94
Identification of the specific Sjogren-syndrome related maternal Ro52 autoantibodies that induce heart block in the fetus during pregnancy
Dzikaite V; Strandberg L; Ambrosi A; Ottosson L; Salomonsson S; Sonesson S-E; Kuchroo V; Wahren-Herlenius M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2007;66:A12
Genetic dissection of congenital heart block in a rat model
Strandberg L; Salomonsson S; Jagodic M; Bechanovic K; Sonesson S-E; Olsson T; Wahren-Herlenius M
Review: AUTOIMMUNITY. 2006;39(3):177-190
Cytokines in idiopathic inflammatory myopathies
Salomonsson S; Lundberg IE
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2006;54(9):S662
Reduced force in muscle from conditional MHC class I transgenic mice, an animal model for idiopathic inflammatory myopathies.
Salomonsson S; Grundtman C; Zhang S-J; Bruton J; Li C; Kanneboyina N; Wedderburn LR; Lundberg IE; Westerblad H
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2006;65:521
Reduced force and fatigue resistance in muscle from conditional MHC class I transgenic mice, an animal model for idiopathic inflammatory myopathies
Salomonsson S; Grundtman C; Zhang S; Bruton J; Li C; Wedderburn L; Westerblad H; Lundberg IE
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2006;65:472
Hyperresponsive IFN-gamma- and TNF-secreting CD28null T cells may contribute to the inflammation in polymyositis and dermatomyositis
Fasth AER; Dastmalchi M; Lindroos E; Salomonsson S; Trollmo C; Lundberg IE; Malmstrom V
Meeting abstract: CLINICAL IMMUNOLOGY. 2006;119:S71
Hyperresponsive TNF- and IFN-γ-secreting CD28null T-Cells may contribute to the inflammation in polymyositis and dermatomyositis.
Fasth A; Dastmolchi M; Lindroos E; Solomonsson S; Trollmo C; Lundberg I
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2005;52(9):S310
Marked expression of IL-1 receptors in muscle fiber membrane and muscle fiber nuclei in patients with polymyositis and dermatomyositis.
Lundberg IE; Grundtman C; Dorph C; Bruton J; Andersson U; Salomonsson S
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2005;64:74
IL-1 receptor expression in muscle fibre membrane and muscle cell nuclei in patients with polymyositis or dermatomyositis
Lundberg IE; Grundtman C; Dorph C; Bruton J; Andersson U; Salomonsson S
Conference publication: CLINICAL IMMUNOLOGY. 2005;115:S129
Genetic dissection of congenital heart block in a rat model.
Horvath LS; Salomonsson S; Jagodic M; Becanovic K; Sonesson SE; Olsson T; Wahren-Herlenius M
Conference publication: CLINICAL IMMUNOLOGY. 2005;115:S119-S120
IL-1 receptor expression in muscle fibre membrane and muscle cell nuclei in patients with polymyositis or dermatomyositis
Lundberg IE; Grundtman C; Dorph C; Barton J; Andersson U; Salomonsson S
Meeting abstract: ARTHRITIS RESEARCH & THERAPY. 2005;7:S33
Marked expression of IL-1 receptors in cell nuclei and muscle fiber membrane in muscle tissue of patients with idiopathic inflammatory myopathies
Grundtman C; Salomonsson S; Dorph C; Burton J; Andersson U; Lundberg IE
Thesis / dissertation: 2004
The role of Ro52 autoantibodies in congenital heart block
Salomonsson, Stina
Conference publication: JOURNAL OF DENTAL RESEARCH. 2003;82:567
Expression of E-cadherin and aEb7 in salivary glands of patients with Sjogren's syndrome.
Jonsson MV; Salomonsson S; Skarstein K
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2003;48(9):S64
Ro52 monoclonal antibodies bind the cell surface of cardiomyocytes
Salomonsson S; Ottosson L; RAats J; Herlenius E; Wahren-Herlenius M
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2002;46(9):S360
Germinal Centers are formed in the target organ in Sjogren's syndrome and are associated with autoantibody production.
Wahren M; Salomonsson S; Jonsson M; Skarstein K; Jonsson R
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2002;46(9):S363
Expression of E-cadherin and aEb7 in salivary glands of patients with Sjogrens's syndrome.
Jonsson MV; Salomonsson S; Skarstein K
Show more

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2023-2026

Degrees and Education

Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2004

About me

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI